Memorial Sloan Kettering Cancer Institute — New York, New York

Memorial Sloan Kettering Cancer Institute is a clinical research site located in New York, New York, United States 10065.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Memorial Sloan Kettering Cancer Institute has participated in 2 clinical trials.

Therapeutic areas: Ovarian Granulosa-Stromal Tumor, Ovarian Granulosa Cell Tumor, Ovarian Cancer.

Sponsors: SpringWorks Therapeutics, Inc., Jazz Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Memorial Sloan Kettering Cancer Institute?

Memorial Sloan Kettering Cancer Institute has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Memorial Sloan Kettering Cancer Institute conducted?

Memorial Sloan Kettering Cancer Institute has 2 clinical trials on record. Their work covers Ovarian Granulosa-Stromal Tumor, Ovarian Granulosa Cell Tumor, Ovarian Cancer.

Is Memorial Sloan Kettering Cancer Institute accredited by Crixeo Health?

Memorial Sloan Kettering Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Memorial Sloan Kettering Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.